Clinical Trial Update: A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) [Phase 2]

View source ↗

Summary

Phase 2 trial of ubenimex in pulmonary arterial hypertension has completed; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• ubenimex (ubenimex)

Snippet

Sponsor: Eiger BioPharmaceuticals | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-03-06